S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
Log in
NASDAQ:CBMG

Cellular Biomedicine Group Short Interest Ratio and Short Volume

$18.24
+0.24 (+1.33 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$17.95
Now: $18.24
$18.34
50-Day Range
$17.82
MA: $18.26
$18.69
52-Week Range
$11.48
Now: $18.24
$19.50
Volume42,117 shs
Average Volume26,651 shs
Market Capitalization$355.28 million
P/E RatioN/A
Dividend YieldN/A
Beta1.35

Short Interest

Cellular Biomedicine Group (NASDAQ:CBMG) Short Interest Data

Current Short Volume:266,600 shares
Previous Short Volume:346,600 shares
Change Vs. Previous Month:-23.08%
Dollar Volume Sold Short:$4.82 million
Short Interest Ratio / Days to Cover:6.0
Last Record Date:December, 31 2020
Outstanding Shares:19,230,000 shares
Float Size:11,460,000 shares
Short Percent of Float:2.33%
Today's Trading Volume:42,117 shares
Average Trading Volume:26,651 shares
Today's Volume Vs. Average:58.03%



Cellular Biomedicine Group (NASDAQ:CBMG) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
12/31/2020266,600 $4.82 million -23.1%2.3%6$18.07
12/15/2020266,600 $4.81 million -23.1%2.3%6$18.06
11/30/2020346,600 $6.29 million -8.9%3.0%6.7$18.16
11/15/2020380,400 $7.00 million 0.3%3.3%5.8$18.39
10/30/2020379,100 $6.58 million -0.9%3.3%3$17.37
10/15/2020382,500 $6.99 million 1.1%3.3%3.1$18.27
9/30/2020378,300 $6.96 million -14.3%3.3%2.8$18.40
9/15/2020441,400 $8.14 million 2.5%3.9%3.1$18.43
8/31/2020430,800 $7.89 million 10.7%3.8%3$18.31
8/14/2020389,200 $7.22 million -31.1%3.4%2.9$18.55
7/31/2020564,700 $10.13 million 8.6%5.0%6.9$17.93
7/15/2020520,100 $6.85 million -2.4%4.6%6$13.17
6/30/2020532,700 $7.13 million 62.3%4.7%6.5$13.38
6/15/2020328,200 $5.35 million 9.3%3.2%4.1$16.30
5/29/2020300,200 $4.60 million 7.6%2.9%3.8$15.31
5/15/2020278,900 $3.84 million -31.8%2.7%3.6$13.77
4/30/2020408,700 $5.60 million -15.3%4.0%5.9$13.70
4/15/2020482,600 $7.03 million -3.4%4.7%7.7$14.57
3/31/2020499,800 $7.32 million -6.3%4.9%8.4$14.65
3/13/2020533,300 $8.53 million 0.9%4.7%9.2$16.00
2/28/2020528,700 $7.77 million 3.1%4.7%9.6$14.70
2/14/2020512,800 $7.74 million -9.9%3.7%9.6$15.09
1/31/2020569,300 $9.55 million 1.5%4.2%10.2$16.78
1/15/2020560,900 $9.39 million 0.1%4.1%9.7$16.74
12/31/2019560,400 $9.58 million 18.8%4.1%10.5$17.10

Cellular Biomedicine Group (NASDAQ:CBMG) Short Interest FAQ

speech bubbles
speech bubbles











What is Cellular Biomedicine Group's current short interest?

Short interest is the volume of Cellular Biomedicine Group shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 266,600 shares of CBMG short. 2.33% of Cellular Biomedicine Group's shares are currently sold short. View details.

What is a good short interest ratio for Cellular Biomedicine Group?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Cellular Biomedicine Group currently has a short interest ratio of 6.0.

What is a good short interest percentage for Cellular Biomedicine Group?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.33% of Cellular Biomedicine Group's floating shares are currently sold short.

Is Cellular Biomedicine Group's short interest increasing or decreasing?

Cellular Biomedicine Group saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 266,600 shares, a decline of 23.1% from the previous total of 346,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Cellular Biomedicine Group's float size?

Cellular Biomedicine Group currently has issued a total of 19,478,000 shares. Some of Cellular Biomedicine Group's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cellular Biomedicine Group currently has a public float of 11,460,000 shares.

How does Cellular Biomedicine Group's short interest compare to its competitors?

2.33% of Cellular Biomedicine Group's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Cellular Biomedicine Group: Krystal Biotech, Inc. (10.00%), Cellectis S.A. (2.09%), Coherus BioSciences, Inc. (21.59%), Alector, Inc. (14.84%), Adverum Biotechnologies, Inc. (0.00%), Mesoblast Limited (0.00%), Sutro Biopharma, Inc. (0.00%), Gritstone Oncology, Inc. (7.41%), TCR2 Therapeutics Inc. (10.12%), and Cortexyme, Inc. (17.62%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.18 billion), ViacomCBS Inc. ($4.71 billion), Analog Devices, Inc. ($4.45 billion), Aon Plc ($4.28 billion), Snap Inc. ($3.70 billion), Moderna, Inc. ($3.00 billion), The Clorox Company ($2.46 billion), Peloton Interactive, Inc. ($2.40 billion), The Kroger Co. ($2.38 billion), and Expedia Group, Inc. ($2.37 billion). View all of the most shorted stocks.

What does it mean to sell short Cellular Biomedicine Group stock?

Short selling CBMG is an investing strategy that aims to generate trading profit from Cellular Biomedicine Group as its price is falling. Cellular Biomedicine Group's stock is trading up $0.24 today. To short Cellular Biomedicine Group stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Cellular Biomedicine Group will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cellular Biomedicine Group?

A short squeeze for Cellular Biomedicine Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CBMG, which in turn drives the price of the stock up even further.

How often is Cellular Biomedicine Group's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CBMG, twice per month. The most recent reporting period available is December, 31 2020.


This page was last updated on 1/22/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.